Pharma job losses ranked

    Where the cuts hit in 2009.

    Of the dozens of drug companies worldwide that downsized this year, Pfizer has the dubious distinction of having made the most lay-offs. According to a top ten list compiled by newsletter FiercePharma in Washington DC, Pfizer slashed 19,500 jobs, partly as a consequence of its US$68-billion acquisition of Wyeth. Merck, which purchased Schering-Plough for $41 billion, came second with 16,000 lay-offs. Cost-cutting prompted Johnson & Johnson, in third place, and AstraZeneca, in fourth, to shed 8,900 and 7,400 jobs, respectively. GlaxoSmithKline cut 6,000 and Eli Lilly was sixth with 5,500.

    Related links

    Related links

    Related links in Nature Research

    Industrial endeavours

    From industry to academia

    Eyeing the underdog

    Related external links

    Top Layoffs of 2009

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Pharma job losses ranked. Nature 462, 1085 (2009).

    Download citation

    Further reading


    By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.